Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Sep 27, 2026; 18(9): 119296
Published online Sep 27, 2026. doi: 10.4240/wjgs.119296
Published online Sep 27, 2026. doi: 10.4240/wjgs.119296
Clinical applicability of synchronous vs sequential transarterial chemoembolization and microwave ablation in hepatocellular carcinoma
Gao-Yi Ruan, Department of Internal Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Zheng Zhu, The Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Zhen-Zhai Cai, Guang-Rong Lu, Qin-Jian Wang, Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Co-first authors: Gao-Yi Ruan and Zheng Zhu.
Co-corresponding authors: Guang-Rong Lu and Qin-Jian Wang.
Author contributions: Wang QJ, Ruan GY and Zhu Z contributed to manuscript writing and editing; Ruan GY and Zhu Z contributed equally to this manuscript as co-first authors; Lu GR and Wang QJ contributed equally to this manuscript as co-corresponding authors; Cai ZZ and Lu GR contributed to conceptualization and critical revisions. All authors have read and approved the final manuscript.
AI contribution statement: During the process of writing the manuscript and answering-reviewers document, I only used translation tools like DeepL and did not use AI tools such as ChatGPT. The main body of the paper (abstract, introduction, materials and methods, results, discussion and conclusion) has not been generated using AI tools. Only DeepL was used to translate and polish some sentences, without using AI tools to analyze data or assist in manuscript writing. AI tools were not involved in the design of the research or the interpretation of the results.
Supported by the Natural Science Foundation of Wenzhou City, No. Y20240207.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Qin-Jian Wang, Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, No. 109 Xueyuan West Road, Wenzhou 325000, Zhejiang Province, China. 571924277@qq.com
Received: January 26, 2026
Revised: February 1, 2026
Accepted: May 19, 2026
Published online: September 27, 2026
Processing time: 235 Days and 3.9 Hours
Revised: February 1, 2026
Accepted: May 19, 2026
Published online: September 27, 2026
Processing time: 235 Days and 3.9 Hours
Core Tip
Core Tip: Combination of transarterial chemoembolization and microwave ablation is an effective locoregional treatment for hepatocellular carcinoma. Synchronous and sequential strategies show similar short-term efficacy and safety, but current evidence is limited by heterogeneity, non-standardized protocols, and insufficient long-term data. Synchronous therapy is suitable for small, solitary tumors with good liver function, whereas sequential therapy is better for large, multifocal tumors or impaired liver reserve. Individualized selection and future prospective, stratified, biomarker-driven studies are needed to optimize clinical practice.